Non- Helicobacter pylori Helicobacters , a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species Specificity.

Autor: Wang W; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; South London and Maudsley NHS Foundation Trust, London SE5 8AB, UK.; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK.; Department of Infectious Diseases, King's College Hospital, London SE5 9RS, UK., Smith M; Department of Infectious Diseases, King's College Hospital, London SE5 9RS, UK., Ellis R; Animal and Plant Health Agency, Weybridge KT15 3NB, UK., Savio A; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK., Nevel A; Agriculture and Horticulture Development Board (AHDB-Pork), Coventry CV3 4PE, UK., Umamahesan C; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; South London and Maudsley NHS Foundation Trust, London SE5 8AB, UK., Pavlidis P; Department of Gastroenterology, King's College Hospital, London SE5 9RS, UK., Hayee BH; Department of Gastroenterology, King's College Hospital, London SE5 9RS, UK., Taylor D; South London and Maudsley NHS Foundation Trust, London SE5 8AB, UK., Young AH; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK., Charlett A; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; Statistics, Modelling and Economics, UK Health Security Agency, London NW9 5EQ, UK., Dobbs SM; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; South London and Maudsley NHS Foundation Trust, London SE5 8AB, UK.; Department of Gastroenterology, King's College Hospital, London SE5 9RS, UK., Dobbs RJ; Host Microbiome Interaction, Clinical Pharmacology and Therapeutics, Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; South London and Maudsley NHS Foundation Trust, London SE5 8AB, UK.; Department of Gastroenterology, King's College Hospital, London SE5 9RS, UK.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 06; Vol. 25 (23). Date of Electronic Publication: 2024 Dec 06.

Faecal metabolite deficit, gut inflammation and diet in Parkinson's disease: Integrative analysis indicates inflammatory response syndrome.

Autor: Augustin A; Institute of Pharmaceutical Science, King's College London, London, UK.; The Maudsley Hospital, London, UK., Guennec AL; NMR Facility, King's College London, London, UK., Umamahesan C; Institute of Pharmaceutical Science, King's College London, London, UK.; The Maudsley Hospital, London, UK., Kendler-Rhodes A; Nutritional Sciences, King's College London, London, UK., Tucker RM; Institute of Pharmaceutical Science, King's College London, London, UK.; The Maudsley Hospital, London, UK., Chekmeneva E; National Phenome Centre, Imperial College London, London, UK.; Section of Bioanalytical Chemistry, Imperial College London, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK., Takis P; National Phenome Centre, Imperial College London, London, UK.; Section of Bioanalytical Chemistry, Imperial College London, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK., Lewis M; National Phenome Centre, Imperial College London, London, UK.; Section of Bioanalytical Chemistry, Imperial College London, London, UK.; Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK., Balasubramanian K; Institute of Pharmaceutical Science, King's College London, London, UK., DeSouza N; The Maudsley Hospital, London, UK., Mullish BH; Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK., Taylor D; Institute of Pharmaceutical Science, King's College London, London, UK.; The Maudsley Hospital, London, UK., Ryan S; Imaging, King's College Hospital, London, UK., Whelan K; Nutritional Sciences, King's College London, London, UK., Ma Y; Institute of Liver Studies, King's College Hospital, London, UK., Ibrahim MAA; Immunological Medicine, King's College Hospital, London, UK., Bjarnason I; Gastroenterology, King's College Hospital, London, UK., Hayee BH; Gastroenterology, King's College Hospital, London, UK., Charlett A; Institute of Pharmaceutical Science, King's College London, London, UK.; Statistics, Modelling and Economics, UK Health Security Agency, London, UK., Dobbs SM; Institute of Pharmaceutical Science, King's College London, London, UK.; Gastroenterology, King's College Hospital, London, UK., Dobbs RJ; Institute of Pharmaceutical Science, King's College London, London, UK.; Gastroenterology, King's College Hospital, London, UK., Weller C; Institute of Pharmaceutical Science, King's College London, London, UK.

Publikováno v: Clinical and translational medicine [Clin Transl Med] 2023 Jan; Vol. 13 (1), pp. e1152.

Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency.

Autor: Tucker RM; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK., Ryan S; Imaging, King's College Hospital, London SE5 9RS, UK., Hayee BH; Gastroenterology, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK., Bjarnason I; Gastroenterology, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK., Augustin AD; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK., Umamahesan C; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK., Taylor D; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK., Weller C; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK., Dobbs SM; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK.; Gastroenterology, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK., Dobbs RJ; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; The Maudsley Hospital, London SE5 8AZ, UK.; Gastroenterology, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK., Charlett A; Institute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.; Statistics, Modelling and Economics, National Infection Service, Public Health England, London NW9 5EQ, UK.

Publikováno v: Journal of clinical medicine [J Clin Med] 2020 Jun 19; Vol. 9 (6). Date of Electronic Publication: 2020 Jun 19.

Helicobacter suis Is Associated With Mortality in Parkinson's Disease.

Autor: Augustin AD; Pharmaceutical Sciences, King's College London, London, United Kingdom.; The Maudsley Hospital, London, United Kingdom., Savio A; Pharmaceutical Sciences, King's College London, London, United Kingdom.; Histopathology, Royal Marsden Hospital, London, United Kingdom., Nevel A; Royal Veterinary College, London, United Kingdom., Ellis RJ; Animal and Plant Health Agency, Weybridge, United Kingdom., Weller C; Pharmaceutical Sciences, King's College London, London, United Kingdom., Taylor D; Pharmaceutical Sciences, King's College London, London, United Kingdom.; The Maudsley Hospital, London, United Kingdom., Tucker RM; Pharmaceutical Sciences, King's College London, London, United Kingdom.; The Maudsley Hospital, London, United Kingdom., Ibrahim MAA; Clinical Immunology, King's College Hospital, London, United Kingdom., Bjarnason I; Gastroenterology, King's College Hospital, London, United Kingdom., Dobbs SM; Pharmaceutical Sciences, King's College London, London, United Kingdom.; The Maudsley Hospital, London, United Kingdom.; Gastroenterology, King's College Hospital, London, United Kingdom., Dobbs RJ; Pharmaceutical Sciences, King's College London, London, United Kingdom.; The Maudsley Hospital, London, United Kingdom.; Gastroenterology, King's College Hospital, London, United Kingdom., Charlett A; Pharmaceutical Sciences, King's College London, London, United Kingdom.; Statistics, Modelling and Economics, Centre for Infectious Disease Surveillance and Control, Public Health England, London, United Kingdom.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2019 Aug 28; Vol. 6, pp. 188. Date of Electronic Publication: 2019 Aug 28 (Print Publication: 2019).

Alpha-synuclein-induced stress sensitivity renders the Parkinson's disease brain susceptible to neurodegeneration.

Autor: Nakos Bimpos, Modestos¹ (AUTHOR), Karali, Katerina^1,2,3 (AUTHOR), Antoniou, Christine^1,3 (AUTHOR), Palermos, Dionysios¹ (AUTHOR), Fouka, Maria¹ (AUTHOR), Delis, Anastasios¹ (AUTHOR), Tzieras, Iason¹ (AUTHOR), Chrousos, George Panagiotis^1,4 (AUTHOR), Koutmani, Yassemi¹ (AUTHOR), Stefanis, Leonidas^1,5 (AUTHOR), Polissidis, Alexia^1,6 (AUTHOR) apolissidis@bioacademy.gr

Publikováno v: Acta Neuropathologica Communications. 6/17/2024, Vol. 12 Issue 1, p1-19. 19p.